ATAI Life Sciences Secures $149.5M to Advance Mental Health Treatments

ATAI Life Sciences just scored nearly $150 million to fuel its mental health drug pipeline! Find out how this major funding round, backed by both new and returning investors, will propel key treatments for conditions like depression through crucial clinical trials and potentially revolutionize mental healthcare by 2029.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.